Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
For Good Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
For Good Ventures

For Good Ventures

Operating

For Good Ventures: An investment firm championing disruptive, world-changing technologies.

Location
San Francisco, CA, US
Founded
2017
Firm
Compare
Portfolio
Employees
Website

Investments

Loliware
Loliware

Total Raised

$15.6M

Rounds

7

Seed$1.7MDecember 2021
Natural Fiber Welding
Natural Fiber Welding

Total Raised

$200.3M

Rounds

10

Series Unknown$15MJuly 2021
Swell Energy
Swell Energy

Total Raised

$582M

Rounds

5

Debt FinancingMarch 2021
Aquacycl
Aquacycl

Total Raised

$14.1M

Rounds

7

Convertible NoteFebruary 2021
Elevian
Elevian

Total Raised

$64.3M

Rounds

6

Seed$15MNovember 2020
Smartbird
Smartbird
Public

Total Raised

$202.4M

Rounds

9

Series E$100MSeptember 2020
Carbon Lighthouse
Carbon Lighthouse

Total Raised

$67.1M

Rounds

8

Convertible NoteAugust 2020
kWh Analytics
kWh Analytics

Total Raised

$26.8M

Rounds

9

Series UnknownJuly 2020
GoodLeap
GoodLeap

Total Raised

$800M

Rounds

2

—March 2020
Good Money
Good Money

Total Raised

$39M

Rounds

4

Series Unknown$9MMarch 2020
Enexor
Enexor

Total Raised

$15M

Rounds

3

Series UnknownFebruary 2020
Copia
Copia

Total Raised

$4.7M

Rounds

5

Seed$1.5MJuly 2019
Convertible NoteApril 2019
Blue Planet Systems
Blue Planet Systems

Total Raised

$9.3M

Rounds

5

Series BJune 2019
SellHound
SellHound

Total Raised

$352.8k

Rounds

7

Convertible NoteMay 2019
Ecolectro
Ecolectro

Total Raised

$15M

Rounds

16

Convertible NoteApril 2019
54Gene
54Gene
Acquired

Total Raised

$94.7M

Rounds

8

Convertible NoteApril 2019
Provenance Biopharmaceuticals
Provenance Biopharmaceuticals
Public

Total Raised

$8M

Rounds

3

Convertible NoteMarch 2019
Convertible NoteAugust 2018
Oova
Oova

Total Raised

$12.5M

Rounds

5

Convertible NoteDecember 2018
Synvivia
Synvivia

Total Raised

$375.9k

Rounds

4

Convertible NoteSeptember 2018
TAE Technologies
TAE Technologies

Total Raised

$1.3B

Rounds

16

Series G$40MSeptember 2018
kegg
kegg

Total Raised

$4.5M

Rounds

7

Convertible NoteAugust 2018
Sixup
Sixup

Total Raised

$43.3M

Rounds

11

Convertible NoteJuly 2018
Mighty Buildings
Mighty Buildings

Total Raised

$153.8M

Rounds

10

Convertible NoteJuly 2018